Page last updated: 2024-09-05

cgp 54626 and ethosuximide

cgp 54626 has been researched along with ethosuximide in 1 studies

Compound Research Comparison

Studies
(cgp 54626)
Trials
(cgp 54626)
Recent Studies (post-2010)
(cgp 54626)
Studies
(ethosuximide)
Trials
(ethosuximide)
Recent Studies (post-2010) (ethosuximide)
570161,09637206

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernasconi, R; Bittiger, H; De Barry, J; Marescaux, C; Mathivet, P1

Other Studies

1 other study(ies) available for cgp 54626 and ethosuximide

ArticleYear
Binding characteristics of gamma-hydroxybutyric acid as a weak but selective GABAB receptor agonist.
    European journal of pharmacology, 1997, Feb-19, Volume: 321, Issue:1

    Topics: Animals; Anticonvulsants; Baclofen; Binding, Competitive; Brain Chemistry; Ethosuximide; GABA Agonists; GABA-B Receptor Agonists; gamma-Aminobutyric Acid; Guanylyl Imidodiphosphate; In Vitro Techniques; Male; Organophosphorus Compounds; Radioligand Assay; Rats; Rats, Wistar; Receptors, GABA-B; Sodium Oxybate; Valproic Acid

1997